ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

  • William Blair 42nd Annual Growth Stock Conference June 8 at 11:20am CT / 12:20pm ET
  • Jefferies Healthcare Conference June 9 at 9:30am ET

A webcast of each presentation will be accessible through the “Investors and Media” section of the Company’s website, Following the live webcast, a replay will be available at the same location.


ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at

INVESTOR RELATIONS AND MEDIA ImmunoGen Courtney O'Konek 781-895-0600


FTI Consulting Robert Stanislaro 212-850-5657

Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more ImmunoGen Charts.
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more ImmunoGen Charts.